Table 3. Distribution of mtDNA haplogroup among HCC pairs/subjects.
| mtDNA haplogroup | M | N | P | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | G | M7 | M8 | M12 | A | N9 | R9(F) | R11 | B | H2 | ||
| HCC patients, n = 86 | 18 | 4 | 14 | 5 | 1 | 8 | 5 | 20 | 2 | 8 | 1 | 0.553 |
| Subjects with somatic variants, n = 35 | 8 | 2 | 5 | 2 | 1 | 6 | 1 | 6 | 1 | 2 | 1 | 0.755 |
| Tumor tissues with reduced mtDNA content, n = 50 | 10 | 2 | 8 | 3 | 1 | 5 | 2 | 13 | 1 | 5 | 0.879 | |